Guard Therapeutics
0,12 SEK +4,8 %Vær den første som følger denne virksomhed
Guard Therapeutics is a developer of pharmaceuticals in the field of oxidative stress. The company focuses primarily on the research, development, and commercialization of pharmaceuticals that are intended to prevent the occurrence and complications of acute kidney damage. In preclinical studies, pharmaceuticals have been shown to protect exposed tissue and support regenerative processes. Treatment of acute kidney injuries in conjunction with heart surgery is a priority in clinical development.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
GUARD
Daglig lav / høj pris
0,112 / 0,124
SEK
Markedsværdi
60,37 mio. SEK
Aktieomsætning
142,07 t SEK
Volumen
1,2 mio.
Finanskalender
Delårsrapport
24.08.2023
Delårsrapport
10.11.2023
Årsrapport
21.02.2024
Viser Alle indholdstyper